Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the study information.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.5.0 applied (updating from v3.4.3).SummaryDifference0.0%

- Check51 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content changes are visible on the page.SummaryDifference0.0%

- Check73 days agoChange Detected- The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1 as a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, with no changes to study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.